Saad, H.K.M.; Abd Rahman, A.A.; Ab Ghani, A.S.; Taib, W.R.W.; Ismail, I.; Johan, M.F.; Al-Wajeeh, A.S.; Al-Jamal, H.A.N.
Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients. Biomedicines 2022, 10, 189.
https://doi.org/10.3390/biomedicines10010189
AMA Style
Saad HKM, Abd Rahman AA, Ab Ghani AS, Taib WRW, Ismail I, Johan MF, Al-Wajeeh AS, Al-Jamal HAN.
Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients. Biomedicines. 2022; 10(1):189.
https://doi.org/10.3390/biomedicines10010189
Chicago/Turabian Style
Saad, Hanan Kamel M., Alawiyah Awang Abd Rahman, Azly Sumanty Ab Ghani, Wan Rohani Wan Taib, Imilia Ismail, Muhammad Farid Johan, Abdullah Saleh Al-Wajeeh, and Hamid Ali Nagi Al-Jamal.
2022. "Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients" Biomedicines 10, no. 1: 189.
https://doi.org/10.3390/biomedicines10010189
APA Style
Saad, H. K. M., Abd Rahman, A. A., Ab Ghani, A. S., Taib, W. R. W., Ismail, I., Johan, M. F., Al-Wajeeh, A. S., & Al-Jamal, H. A. N.
(2022). Activation of STAT and SMAD Signaling Induces Hepcidin Re-Expression as a Therapeutic Target for β-Thalassemia Patients. Biomedicines, 10(1), 189.
https://doi.org/10.3390/biomedicines10010189